Alkyl and Aryl Derivatives Based on p -Coumaric Acid Modification and Inhibitory Action against Leishmania braziliensis and Plasmodium falciparum

In low-income populations, neglected diseases are the principal cause of mortality. Of these, leishmaniasis and malaria, being parasitic, protozoan infections, affect millions of people worldwide and are creating a public health problem. The present work evaluates the leishmanicidal and antiplasmodial action of a series of twelve -coumaric acid derivatives. Of the tested derivatives, eight presented antiparasitic activities - , - . The hexyl -coumarate derivative ( ) (4.14 ± 0.55 μg/mL; selectivity index (SI) = 2.72) showed the highest leishmanicidal potency against the amastigote form. The results of the molecular docking study suggest that this compound inhibits aldehyde dehydrogenase (ALDH), mitogen-activated kinase protein (MPK4), and DNA topoisomerase 2 (TOP2), all of which are key enzymes in the development of . The data indicate that these enzymes interact via Van der Waals bonds, hydrophobic interactions, and hydrogen bonds with phenolic and aliphatic parts of this same compound. Of the other compounds analyzed, methyl -coumarate (64.59 ± 2.89 μg/mL; IS = 0.1) demonstrated bioactivity against . The study reveals that esters presenting a -coumarate substructure are promising for use in synthesis of derivatives with good antiparasitic profiles.